Stent for Life Initiative: Leading example in building STEMI systems of care in emerging countries

EuroIntervention

Volumn 10, Issue t, 2014, Pages T87-T95

  Kaifoszova, Zuzana ^a   Kala, Petr ^b   Alexander, Thomas ^c   Zhang, Yan ^d   Huo, Yong ^e   Snyders, Adriaan ^f   Delport, Rhena ^g   Alcocer Gamba, Marco Antonio ^h   Gavidia, Leslie Marisol Lugo ^h  

^a HELIS Partners Consulting   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c Kovai Medical Center and Hospital   (India)

^d University First Hospital   (China)

^e PEKING UNIVERSITY FIRST HOSPITAL   (China)

^f Wilgers Hospital   (South Africa)

^g UNIVERSITY OF PRETORIA   (South Africa)

^h UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

Author keywords

Coronary artery disease; Emergency medical service; Primary percutaneous coronary intervention; Reperfusion; ST elevation acute myocardial infarction

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CHINA; CORONARY REPERFUSION; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; GOVERNMENT; HEALTH CARE UTILIZATION; HUMAN; INDIA; MEDICAL EDUCATION; MEXICO; PERCUTANEOUS CORONARY INTERVENTION; PILOT STUDY; PREVALENCE; REGISTER; SOUTH AFRICA; SOUTH AND CENTRAL AMERICA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; EUROPE; HEALTH CARE DELIVERY; HEART MUSCLE REPERFUSION; MYOCARDIAL INFARCTION; PROCEDURES; STENT;

DELIVERY OF HEALTH CARE; EMERGENCY MEDICAL SERVICES; EUROPE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PERCUTANEOUS CORONARY INTERVENTION; STENTS;

EID: 84930802948     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10STA14     Document Type: Article

References (34)

1. Gupta R. Burden of coronary heart disease in India. Indian Heart J. 2005;57:632-8.
2. Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, Gupta R, Joshi P, Kerkar P, Thanikachalam S, Haridas KK, Jaison TM, Naik S, Maity AK, Yusuf S; CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371:1435-42.
3. Alexander T, Mehta S, Mullasari A, Nallamothu BK. Systems of care for ST-elevation myocardial infarction in India. Heart. 2012;98:15-7.
4. Alexander T, Victor SM, Mullasari AS, Veerasekar G, Subramaniam K, Nallamothu BK; TN-STEMI Programme Investigators. Protocol for a prospective, controlled study of assertive and timely reperfusion for patients with ST-segment elevation myocardial infarction in Tamil Nadu: the TN-STEMI programme. BMJ Open. 2013;3:e003850.
5. Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, Wan X, Yu S, Jiang Y, Naghavi M, Vos T, Wang H, Lopez AD, Murray CJ. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013;381:1987-2015.
6. The World Bank. Toward a healthy and harmonious life in China: stemming the rising tide of non-communicable diseases. http://www.worldbank.org/content/dam/Worldbank/document/NCD-report-en.pdf (accessed Nov 27, 2013).
7. Li J, Li X, Wang Q, Hu S, Wang Y, Masoudi FA, Spertus JA, Krumholz HM, Jiang L; for the China PEACE Collaborative Group. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet. 2014 Jun 23. pii: S0140-6736(14)60921-1. doi: 10.1016/S0140-6736(14)60921-1. [Epub ahead of print]
8. Huo Y. Current status and development of percutaneous coronary intervention in China. J Zhejiang Univ Sci B. 2010;11:631-3.
9. Zhang Y, Huo Y. Early reperfusion strategy for acute myocardial infarction: a need for clinical implementation. J Zhejiang Univ Sci B. 2011;12:629-32.
10. Ranasinghe I, Rong Y, Du X, Wang Y, Gao R, Patel A, Wu Y, Iedema R, Hao Z, Hu D, Turnbull F; CPACS Investigators. System barriers to the evidence-based care of acute coronary syndrome patients in China: qualitative analysis. Circ Cardiovasc Qual Outcomes. 2014;7:209-16.
11. Schamroth C; ACCESS South Africa investigators. Management of acute coronary syndrome in South Africa: insights from the ACCESS (Acute Coronary Events - a Multinational Survey of Current Management Strategies) registry. Cardiovasc J Afr. 2012;7:365-70.
12. Terkelsen CJ, Sørensen JT, Maeng M, Jensen LO, Tilsted HH, Trautner S, Vach W, Johnsen SP, Thuesen L, Lassen JF. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304:763-71.
13. Peterson MC, Syndergaard T, Bowler J, Doxey R. A systematic review of factors predicting door to balloon time in ST-segment elevation myocardial infarction treated with percutaneous intervention. Int J Cardiol. 2012;157:8-23.
14. About the City of Tshwane. http://www.tshwane2055.gov.za/home/about-tshwane/the-city (accessed 14/04/2014).
15. The local government handbook. Census 2011 Municipal Fact Sheet. Published by Statistics South Africa. (2013/10/05). http://www.localgovernment.co.za/metropolitans/demographics/3 (accessed 2014/04/14).
16. American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions, O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78-140.
17. Sosa Liprandi MI, González MA, Rivero Ayerza M, Iglesias RM, Vilar de Saráchaga D, Sosa Liprandi A. Tendencias de la mortalidad por infarto agudo de miocardio en la República Argentina durante el período 1980-1997. Rev Argent Cardiol. 1999;67:733-8.
18. Sosa Liprandi MI, Harwicz P, Sosa Liprandi A. Causas de muerte en la mujer y su tendencia en los últimos 23 años en la Argentina. Rev Argent Cardiol. 2006;74:297-303.
19. Oliveira GM, Klein CH, Souza e Silva NA, Godoy P, Fonseca TM. [Ischemic heart disease lethalities in the state of Rio de Janeiro between 1999 and 2003]. Arq Bras Cardiol. 2006;86:131-7.
20. Cohen M. Latinoamérica en los ensayos clínicos internacionales: Dónde está la diferencia? Son los pacientes, los médicos o el sistema? Rev Argent Cardiol. 2003;71:6-15.
21. Mele EF. [Progress in reperfusion after acute myocardial infarction. The situation in Latin America]. Rev Esp Cardiol. 2010;63 Suppl 2:12-9.
22. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis. JAMA. 2000;283:2686-92.
23. Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz HR, Bogaerts K, Danays T, Lindahl B, Mäkijärvi M, Verheugt F, Van de Werf F. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation. 2003;108:135-42.
24. Bonnefoy E, Steg PG, Boutitie F, Dubien PY, Lapostolle F, Roncalli J, Dissait F, Vanzetto G, Leizorowicz A, Kirkorian G; CAPTIM Investigators, Mercier C, McFadden EP, Touboul P. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J. 2009;30:1598-606.
25. Araújo DV, Tura BR, Brasileiro AL, Luz Neto H, Pavão AL, Teich V. Cost-effectiveness of prehospital versus inhospital thrombolysis in acute myocardial infarction. Arq Bras Cardiol. 2008;90:91-8.
26. Rosas-Peralta M, Attie F. [Cardiovascular disease. First cause of death in adults in Mexico and worldwide]. Arch Cardiol Mex. 2007;77:91-3.
27. Velázquez Monroy O, Barinagarrementería Aldatz FS, Rubio Guerra AF, Verdejo J, Méndez Bello MA, Violante R, Pavía A, Alvarado-Ruiz R, Lara Esqueda A. [Morbidity and mortality by ischemic heart disease and stroke in Mexico. 2005]. Arch Cardiol Mex. 2007;77:31-9.
28. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790-7.
29. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Lancet. 2002;360:861-8.
30. Encuesta Nacional de Salud y Nutrición [ENSANUT] SSA. 2006.
31. Lupi Herrera E. [National registry of Acute Ischemic Coronary Syndromes (RENASICA). Mexican Cardiology Society. The RENASICA Cooperative Group]. Arch Cardiol Mex. 2002;72 Suppl 2:S45-64.
32. García-Castillo A, Jerjes-Sánchez C, Martínez Bermúdez P, Azpiri-López JR, Autrey Caballero A, Martínez Sánchez C, Ramos Corrales MA, Llamas G, Martínez Sánchez J, Treviño AJ; RENASICA II. Mexican Registry of Acute Coronary Syndromes. Arch Cardiol Mex. 2005;75 Suppl 1:S6-32.
33. Allende R, Baños AZ, De los Rìos O, Carrillo J, Rivera JJ, Pèrez-Alva JC, Leiva-Pons JL. Interventional Cardiology and Transradial Approach in Mexico. J Invasive Cardiol. 2013;25(Suppl E):3E-4E.
34. Leiva J, Alcocer M, Rivera J, Garcìa E, Lòpez J, Manautou L, Chavez E, Vazquez P, Virgen L, de los Rìos O, grupo SOCIME Mèxico. Adherencia a los lineamientos internacionales de manejo peri intervenciòn en Mèxico: resultados de la fase piloto del nuevo registro de intervenciones cardiovasculares de la Sociedad de Cardiologia Intervencionista de Mexico. Congreso SOLACI, Santiago de Chile, Chile, August 2011.